Overall Status

Completed (19)

Active, not recruiting (7)

Recruiting (4)

Terminated (3)

Unknown status (1)

Sign in for free

Phase

phase 3 (12)

phase 2 (11)

phase 1 (6)

phase 1/phase 2 (3)

phase 2/phase 3 (1)

Collaborator

Medivation, Inc. (2)

AstraZeneca (1)

Bristol-Myers Squibb (1)

Daiichi Sankyo, Inc. (1)

Eisai Inc. (1)

Genentech, Inc. (1)

Myriad Genetic Laboratories, Inc. (1)

Study Documents

Intervention Type

drug (32)

biological (1)

combination product (1)

device (1)

other (1)

Funder Type

Industry (31)

Other (3)

Study Type

Interventional (33)

Observational (1)

breast neoplasms

Showing NaN - NaN of 34

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS